Atlas Trials

Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)

Clinical trial NCT01528241 · COMPLETED

Trial details

NCT number
NCT01528241
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depression
Start date
2008-08-01
Primary completion
2010-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.